MRT Symposium 2023

DOSIsoft participates in the Symposium on Molecular Radiotherapy Dosimetry: The Future of Theragnostics

November 9-11, 2023 | Athens, Greece

PLANET Product Show

Come and check the advanced features of PLANET® Dose – Patient-specific, multi-radionuclide (90Y/177Lu/131I/166Ho) & theranostics platform for Molecular Imaging & Molecular RadioTherapy dosimetry.

PLANET® Onco: Oncology software for Molecular Imaging (MI) & Radiotherapy. It helps to optimize disease diagnosis & therapy through registration, contouring, advanced quantification & patient response from multimodal imaging. Texture analysis for diagnosis, follow-up & radiomics is provided.

PLANET® Dose: Dosimetry software for Molecular RadioTherapy (MRT) providing multiple and integrated workflow for 90Y/177Lu/131I/166Ho dosimetry. It allows to personalize patient therapy through pre/post-implementation dosimetry, automatic structure propagation, calculation of residence time & comparison between treatment planning & validation control dose maps. Consolidation of multi-treatment stages is available.

Oral Presentation & Abstracts

Thursday, November 9, 2023 | Sponsor Session: product presentation

16:30 – 16:45 | DOSIsoft Planet Dose a multi-radionuclide platform for voxel-based personalized dosimetry by Chahrazed Ghannoudi at DOSIsoft

18:15 – 18:30 | Clinical experience in MRT dosimetry using Planet Onco Dose software by Ioanna Stamouli at Karvonis

Friday, November 10, 2023 | Session 4: Time-related variables, TAC fitting and PK assessment

9:30 – 9:40 | Clinical Dosimetry Workflow comparison with OpenDose3D in molecular radiotherapy by J. Fragoso Negrin, M. Bardiès  See the abstract 85 >

10:10 – 10:20 | Absorbed dose rate algorithm comparison in 177Lu-based molecular radiotherapy dosimetry by J. Fragoso Negrin  See the abstract 84 >

Saturday, November 11, 2023 | Session 7: Quality Assurance in clinical dosimetry

 9:30 – 9:40 | OpenDose3D, an open-source software for advancing clinical molecular radiotherapy dosimetry. by J. Fragoso Negrin, M. Bardiès See the abstract 86 >

Click on the link provided for more information:  SMRD2023